Cost-utility Study of a Group of Compensatory Cognitive Remediation in Schizophrenia

NCT ID: NCT02879604

Last Updated: 2025-09-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

218 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-03-05

Study Completion Date

2023-03-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Significant cognitive impairment (executive functions, memory, attention) is common in schizophrenia affecting up to 80% of patients. But pharmacological treatments (typical and atypical antipsychotic) do not have impact on cognitive functioning. For over 20 years, alternative non-pharmacological therapeutics have been developed in schizophrenia. These techniques called cognitive remediation specifically target cognitive deficits. The first cognitive remediation available for patients was designed to stimulate new learning, or relearning, of cognitive tasks, and thus to improve certain deficient domains. These procedures were efficient in improving cognition as measured by neurocognitive tests but their impact on functioning and daily life was weak. In a second time, compensatory remediation has been developed. Compensatory approaches seek to make improvements in the patient's functioning by avoiding areas of impairment and recruiting other intact cognitive domains or by creating a supportive external environment. In recent meta-analysis compensatory remediation has larger effect-size than classical cognitive remediation, with an impact on patients psychosocial functioning. Recently, Dr E. Twamley (University of California) developed and tested a group-based, manualized, compensatory cognitive training intervention.

Compensatory cognitive training (CCT) is a low-tech, brief intervention and is easily transposable in community care. Our team translated this method into French. The investigators planned a cost -utility study between CCT and treatment as usual in schizophrenia patients with less than 10 years of evolution.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will take place over 3 years with a recruitment period of 18 months. After verification of the eligibility criteria and signature of the consent, the patients will be divided into 2 groups by randomization: the intervention group and the control group. The duration of participation of the subjects will be 12 months. Assessments are available in 4 steps (V1 at inclusion, V2 at 3 months, V3 at 6 months and V4 at 12 months). These visits include an assessment of the functioning of patients, symptomatology, quality of life, treatment and care received at all visits, occupational activity and cognitive assessment and social knowledge at V1 and V4.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Schizophrenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Compensatory cognitive training

Compensatory cognitive training

Group Type EXPERIMENTAL

Compensatory cognitive training

Intervention Type OTHER

In addition to the usual care, method of compensatory cognitive remediation

usual treatment

usual treatment for shizophrenai

Group Type PLACEBO_COMPARATOR

Usual

Intervention Type OTHER

Usual care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Compensatory cognitive training

In addition to the usual care, method of compensatory cognitive remediation

Intervention Type OTHER

Usual

Usual care

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

CCT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnostic with schizophrénie
* Less than 10 years of the evolution of the disease

Exclusion Criteria

* History of severe cranial trauma and / or neurological pathology with cognitive impairment
* Ongoing participation in another study for treatment of negative or cognitive symptoms
* Ongoing participation in a study on management in psychotherapy for cognitive disorders and negative symptoms
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique Hopitaux De Marseille

OTHER

Sponsor Role collaborator

University Hospital, Clermont-Ferrand

OTHER

Sponsor Role collaborator

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role collaborator

Hôpital Louis Mourier

OTHER

Sponsor Role collaborator

Centre Hospitalier Charles Perrens, Bordeaux

OTHER_GOV

Sponsor Role collaborator

University Hospital, Strasbourg

OTHER

Sponsor Role collaborator

Hospital Center Alpes-Isère

OTHER

Sponsor Role collaborator

Hôpitaux à Bron

OTHER

Sponsor Role collaborator

Fondation FondaMental

OTHER

Sponsor Role collaborator

University Hospital, Montpellier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Delphine DC CAPDEVIELLE, MD-PhD

Role: STUDY_DIRECTOR

Montpellier University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Charles Perrens Hospital

Bordeaux, , France

Site Status

Le Vinatier Hospital

Bron, , France

Site Status

Gabriel-Montpied Univesity Hospital

Clermont-Ferrand, , France

Site Status

Louis Mourier Hospital

Colombes, , France

Site Status

Chenevier Hospital

Créteil, , France

Site Status

La Conception Hospital

Marseille, , France

Site Status

Montpellier University Hospital

Montpellier, , France

Site Status

Alpes Isère Hospital

Saint-Égrève, , France

Site Status

Strasbourg University Hospital

Strasbourg, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RECHMPL15_0503

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.